An independent Israeli group of physicians, lawyers, scientists, and researchers called the Professional Ethics Front today advised the U.S. Food and Drug Administration (FDA) regarding the upcoming FDA discussion on administering COVID-19 vaccines to children aged 5-11, expressing “severe concerns” regarding the reliability and legality of official Israeli COVID vaccine data.
The letter is signed by Dr. Sorin Schapira, MBA, Eitan Marchand, Dr. Moran Kronenberg, Dr. Sergei Bianover, Ph.D, Prof. Alon Warburg, Dr. Boaz Ilan, Prof. Eti Einhorn, Dr. Daniel Mishori, Adv. Orly Yaron, Prof. Natti Ronel, Dr. Ety Elisha, Adv. Dana Kovalskiy, Adv. Galit Polatchek, Adv. Yoram Morim, Dr. Yaffa Shir-Raz, Adv. Yossi Bitton, Adv. Valentina Nelin, Dr. Ilan Makover, MD, Osnat Navon, Dr. Itsik Vorgaft, and Dr. Yael Stein, MD.
“We are aware that the state of Israel is perceived as ‘the world laboratory’ regarding the safety and efficacy of the Pfizer-BioNTech COVID-19 vaccine, as reflected by statements made by Dr. Albert Bourla, Dr. Anthony Fauci, and other senior figures in leading health authorities throughout the world,” the letter reads. “It is therefore our understanding that the data and information coming from Israel play a crucial role in critical decision-making processes in regards to COVID-19 vaccination policies. We thus see it of utmost importance to convey a message of warning and raise our major concerns regarding potential flaws in the reliability of the Israeli data with respect to the Pfizer-BioNTech COVID-19 vaccine, as well as many significant legal and ethical violations that accompany the data collection processes.”
The letter elaborates: “We believe that the significant failures underlying the Israeli database, which have been brought to our attention by numerous testimonies, impair its reliability and legality to such an extent that it should not be used for making any critical decisions regarding the COVID-19 vaccines.”
America’s Frontline Doctors (AFLDS) spoke to Haifa and Reichman Universities Health and Risk Communication lecturer Dr. Yaffa Shir Raz, one of the letter’s authors, about their findings and conclusions:
CONTINUE READING & WATCH INTERVIEW: DR YAFFA SHIR RAZ